Indication
Spinal Muscular Atrophy
The Spinal Muscular Atrophy pipeline: 3 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Spinal Muscular Atrophy, so this list is not complete.
1 approved / phase 42 Phase 3
Compare the share prices of listed companies in Spinal Muscular Atrophy →
Market size not yet sourced. How markets are sized ↗